83 completed, 21 unknown, 16 recruiting, 5 terminated. 137 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 137 | Completed 83, Unknown 21, Recruiting 16, Terminated 5, Withdrawn 5, Not yet recruiting 4, Active not recruiting 3 |
Follow Vaginitis: new trials by email Literature Review of Vaginitis trials Research Report on Vaginitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Photobiomodulation With Blue LED in Recurrent Bacterial Vaginosis Metronidazole, Blue Light-Emitting Diode (LED) - Bacterial Vaginosis | Not applicable | Not yet recruiting | Patricia Lordelo | 40 | 2026-09-30 | 2026-09-23 |
| Improving Maternal and Child Health Through Point-of-care STI Testing Point-of-care STI tests, Standard of care STI testing - Treponema Pallidum Infection, Chlamydia Trachomatis Infection | Not applicable | Recruiting | Emory University | 756 | 2026-08-11 | 2026-08-19 |
| Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient Treatment Blue LED Photobiomodulation - Genitourinary Syndrome of Menopause (GSM), Bacterial Vaginosis | Not applicable | Not yet recruiting | Patricia Lordelo | 150 | 2026-07-30 | 2026-07-13 |
| F-GYN for Vaginal Dryness and Vulvovaginal Atrophy F-GYN Non-Crosslinked Hyaluronic Acid Injectable Gel, Standard Non-Hormonal Symptomatic Care - Atrophic Vaginitis, Atrophic Vulvovaginitis | Not applicable | Recruiting | Biovico Sp. z o.o. | 130 | 2026-07-24 | 2026-10-01 |
| Efficacy and Safety of a Vaginal Ovule Medical Device for Bacterial Vaginosis and Candidal Vaginitis (ROVUL25). Class IIa vaginal medical device supplied as vaginal ovules, intended as an adjuvant in prevention of vaginal infections and symptoms., Placebo. - Bacterial Vaginosis, Candidal Vaginitis | Not applicable | Not yet recruiting | ROELMI HPC | 80 | 2026-07-09 | 2026-07-14 |
| Evaluation of the Efficacy of a Probiotic Product as an Adjuvant Treatment for Vulvovaginal Candidiasis Bioithas WOMAN® - Vulvovaginal Candidiasis (VVC) | Not applicable | Recruiting | Bioithas SL | 60 | 2026-05-25 | 2026-05-22 |
| The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study Vaginal lactoferrin, Usual care - Bacterial Vaginosis, Candida Vaginal | Not applicable | Recruiting | Guy's and St Thomas' NHS Foundation Trust | 114 | 2026-04-16 | 2026-05-29 |
| Evaluation of the Ability of Lactobacillus Crispatus CRP21 to Reduce the Incidence of Recurrent Bacterial Vaginosis Lactobacillus crispatus CRP21, Placebo - Recurrent Bacterial Vaginosis | Not applicable | Recruiting | Liaquat University of Medical & Health Sciences | 132 | 2026-03-23 | 2026-09-02 |
| An Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Vulvovaginal Candidiasis Compared With an Untreated Control Group pHyph - Vulvovaginal Candidiasis (VVC) | Not applicable | Active not recruiting | Gedea Biotech AB | 48 | 2026-03-03 | 2026-05-14 |
| The Effects of Adjunctive Therapy With Vaginal Tablets Lactobacillus Acidophilus and a Low Dose Estriol (Gynoflor®) to Prolong Pregnancy Time in Preterm Labor, A Randomized Controlled Trial Gynoflor - Threaten Preterm, Prethrem Labour | Not applicable | Not yet recruiting | Queen Savang Vadhana Memorial Hospital, Thailand | 80 | 2026-02-01 | 2026-01-15 |
| An Open Single-armed Investigation to Evaluate the Safety of pHyph Following a Prolonged Treatment Duration in Adult Women With Bacterial Vaginosis pHyph - Bacterial Vaginosis (BV) | Not applicable | Completed | Gedea Biotech AB | 32 | 2026-01-15 | 2026-04-13 |
| Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis Tinidazole 56, Tinidazole 42 - Trichomonas Vaginitis | Not applicable | Unknown | Shangrong Fan | 20 | 2025-12-01 | 2024-06-11 |
| Multi-Gyn FemiTotal for the Treatment and Prevention of Vulvovaginal Candidiasis Symptoms and Bacterial Vaginosis Multi-Gyn FemiTotal - Bacterial Vaginosis, Vaginal Candidiasis | Not applicable | Recruiting | Karo Pharma AB | 80 | 2025-10-22 | 2026-10-02 |
| Light Treatment of Vaginal Infections in Reproductive Age Women Vaginal light therapy - Once, Vaginal Light Therapy - Once, Vaginal Light Therapy - Twice - Bacterial Vaginosis, Vulvovaginal Candidiases | Not applicable | Completed | UVISA Health ApS | 38 | 2025-06-05 | 2026-02-17 |
| Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC) vaginal cooling device - Vulvovaginal Candidiasis (VVC), Yeast Vaginitis | Not applicable | Recruiting | Coologics, Inc | 55 | 2025-05-22 | 2026-01-30 |
| Evaluation of the Medical Device Vagitab - T as Adjuvant Therapy in Patients With Bacterial Vaginosis. Vagitab -T vaginal tablets. Components: tyndallized probiotic L. plantarum HA-119, lactic acid, and xylo-oligosaccharides, lauryl glucoside, and macrogol 3350: - Bacterial Vaginosis (BV), Recurrent Bacterial Vaginosis | Not applicable | Recruiting | S.I.I.T. Srl | 30 | 2025-03-31 | 2025-05-28 |
| Clinical Protocol CERN Feasibility Study Cern Device - Bacterial Vaginosis, Fungal Vaginal Infections | Not applicable | Recruiting | Cern Corporation | 9 | 2024-11-06 | 2025-04-18 |
| A Clinical Study to Determine the Safety and Efficacy of an Oral Probiotic Supplementation to Improve Bacterial Vaginosis in Females MetSheFlora - Vaginal Health - Bacterial Vaginosis | Not applicable | Completed | NovoBliss Research Pvt Ltd | 14 | 2024-10-21 | 2025-03-03 |
| Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis Probiotic, Placebo - Vulvovaginal Candidiasis | Not applicable | Recruiting | The Archer-Daniels-Midland Company | 126 | 2024-10-15 | 2024-11-07 |
| A Study to Evaluate the Effects of a Prebiotic and Probiotic Supplement to Provide Relief From Symptoms Associated With Bacterial Vaginosis and Yeast Infections. Prebiotic + Probiotic Supplement, Active Placebo Supplement, Excipient Placebo Supplement - Bacterial Vaginosis, Yeast Infection | Not applicable | Completed | Happy V | 120 | 2024-10-04 | 2026-08-13 |
Showing 20 of 137. Sign in to see all of them.
Vaginosis, Bacterial (73) · Candidiasis, Vulvovaginal (30) · Atrophic Vaginitis (12) · Vaginal Diseases (9) · Urinary Tract Infections (6) · Vaginal Discharge (6) · Candidiasis (5) · Vulvovaginitis (5) · Recurrence (4) · Sexually Transmitted Diseases (4) · Trichomonas Vaginitis (4) · Anxiety Disorders (3) · Depression (3) · Genital Diseases, Female (3)
Female Urogenital Diseases (137) · Female Urogenital Diseases and Pregnancy Complications (137) · Genital Diseases (137) · Urogenital Diseases (137) · Genital Diseases, Female (134) · Vaginal Diseases (128) · Infections (106) · Bacterial Infections and Mycoses (100) · Bacterial Infections (75) · Vulvar Diseases (34) · Vulvitis (33) · Mycoses (31) · Vulvovaginitis (28) · Candidiasis (26)
Metronidazole (10) · Probiotics (4) · Fluconazole (3) · 6-phospho-beta-galactosidase (1) · Anti-Bacterial Agents (1) · Benchmarking (1) · Cefazolin (1) · Cholecalciferol (1) · Clindamycin (1) · Clotrimazole (1) · Control Groups (1) · Culture Techniques (1) · Estradiol (1) · Estriol (1) · Estrogens, Conjugated (USP) (1)
Gedea Biotech AB (7) · Karo Pharma AB (3) · PepTonic Medical AB (3) · Stratpharma AG (3) · Anabio R&D (2) · Atlantic Health System (2) · Centro de Atenção ao Assoalho Pélvico (2) · HaEmek Medical Center, Israel (2) · Hadassah Medical Organization (2) · Herbarium Laboratorio Botanico Ltda (2) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2) · Medical University of Vienna (2) · Padagis LLC (2) · Patricia Lordelo (2) · University Ghent (2)
United States (29) · Sweden (10) · Brazil (7) · Italy (7) · France (6) · Israel (6) · United Kingdom (6) · Spain (5) · China (4) · Germany (4) · Taiwan (4) · Egypt (3) · Poland (3) · Romania (3) · Austria (2)
Monika Cardell, MD, PhD (2) · Robert Hodge, MD (2) · Abigail Norris Turner, PhD (1) · Adrian Gaspar, MD (1) · Ahinoam Lev-Sagie, MD (1) · Aino Fianu Jonasson, Ass. Prof. (1) · Aino Fianu Jonasson, MD, PhD (1) · Aleksandra M Cichonska, PhD (1) · Allison K Groves, PhD, MHS (1) · Andrea R Thurman, MD (1) · Anh TV Nguyen, Assoc. Prof. (1) · Anh TV Nguyen, PhD. (1) · Armin Witt, MD (1) · Ashwin Chatwani, M.D. (1)
PMID 40709601, PMID 20027045, PMID 20428282, PMID 21263351, PMID 21789604, PMID 21876923, PMID 23710844, PMID 23746776, PMID 24949544, PMID 25452591, PMID 26635090, PMID 28494795, PMID 28807017, PMID 28903767, PMID 29637269, PMID 30406341, PMID 31189673, PMID 31340789, PMID 31404542, PMID 31574047, PMID 31591599, PMID 32434932, PMID 33181518, PMID 33184437, PMID 33207004, PMID 33514681, PMID 33939124, PMID 34560047, PMID 35005777, PMID 36395084, PMID 37384600, PMID 37471117, PMID 37474354, PMID 38085184, PMID 39035147, PMID 39836629, PMID 40990120, PMID 41258468, PMID 41388307, PMID 41404945, PMID 41471856, PMID 42117698, PMID 42464124, PMID 42541233, PMID 42628955
KL2RR025754 (1), P30AI027757 (1), R01MD020754 (1), R03TW005820 (1)